Biotech · Private company · San Diego, CA, US
Orphagen Pharmaceuticals
Track this companyFree. Adds Orphagen Pharmaceuticals to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- A novel, pleiotropic oral drug class that inhibits gut migration of activated T cellsFiscal year 2025 · $634.1KNIH RePORTER 5R44DK136458-02 · fetched Nov 12, 2026
- A novel, pleiotropic oral drug class that inhibits gut migration of activated T cellsFiscal year 2024 · $1.1MNIH RePORTER 1R44DK136458-01A1 · fetched Nov 12, 2026